Neuro-Oncology Reviews




Volume 22 Number 9
15 May 2020




Home > Publications > Neuro-Oncology Reviews > Volume 22, Year 2020 > Number 9, 15 May






Li R, Li C, Cai Z, Li L, Wei L, Qian Z, Zhou D.
Comparative efficacy of antiangiogenic treatment for newly diagnosed glioblastoma: A protocol for systematic review and network meta-analysis.
Medicine (Baltimore). 2020 May;99(19):e20011. doi: 10.1097/MD.0000000000020011. PMID: 32384458. Review, Meta-analysis. ˍ




Armstrong TS, Chang SM, Jenkinson D, Kluetz P, Taphoorn MJB.
Glioma patient-reported outcome assessment in clinical care - Authors' reply.
Lancet Oncol. 2020 May 1;21(5):e231. doi: 10.1016/S1470-2045(20)30241-2. PMID: 32359496. Comment. ˍ
REFERS TO: Tuleasca C, et al.,Glioma patient-reported outcome assessment in clinical care. Lancet Oncol. 2020 May 1;21(5):e230. doi: 10.1016/S1470-2045(20)30141-8. PMID: 32359495. Comment. ˍ
IN TURN REFERRING TO: Armstrong TS, et al.,Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report. Lancet Oncol. 2020 Feb 1;21(2):e97-e103. doi: 10.1016/S1470-2045(19)30796-X. PMID: 32007210. Review. ˍ




Tuleasca C, Knisely J, Leroy HA, Hottinger AF, Peciu-Florianu I, Levivier M, Reyns N.
Glioma patient-reported outcome assessment in clinical care.
Lancet Oncol. 2020 May 1;21(5):e230. doi: 10.1016/S1470-2045(20)30141-8. PMID: 32359495. Comment. ˍ
REFERS TO: Armstrong TS, et al.,Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report. Lancet Oncol. 2020 Feb 1;21(2):e97-e103. doi: 10.1016/S1470-2045(19)30796-X. PMID: 32007210. Review. ˍ




Abdalla G, Dixon L, Sanverdi E, Machado PM, Kwong JSW, Panovska-Griffiths J, Rojas-Garcia A, Yoneoka D, Veraart J, Van Cauter S, Abdel-Khalek AM, Settein M, Yousry T, Bisdas S.
The diagnostic role of diffusional kurtosis imaging in glioma grading and differentiation of gliomas from other intra-axial brain tumours: a systematic review with critical appraisal and meta-analysis.
Neuroradiology. 2020 May 4;62(7):791-802. doi: 10.1007/s00234-020-02425-932367349. PMID: 32367349. Review, Meta-analysis. ˍ




Collins KL, Pollack IF.
Pediatric Low-Grade Gliomas.
Cancers (Basel). 2020 May 4;12(5):E1152. doi: 10.3390/cancers12051152. PMID: 32375301. Review. ˍ




Dimou J, Kelly J.
The biological and clinical basis for early referral of low grade glioma patients to a surgical neuro-oncologist.
J Clin Neurosci. 2020 May 4;78:20-29. doi: 10.1016/j.jocn.2020.04.119. PMID: 32381393. Review. ˍ




Huang M, Patel J, Patel BC.
Optic Nerve Glioma.
StatPearls. 2020 May 4. NCBI Bookshelf ID: NBK557878. PMID: 32491801. Book. ˍ




Simon T, Jackson E, Giamas G.
Breaking through the glioblastoma micro-environment via extracellular vesicles.
Oncogene. 2020 May 4;39(23):4477-4490. doi: 10.1038/s41388-020-1308-2. PMID: 32366909. Review. ˍ




Weller M, Le Rhun E.
How did lomustine become standard of care in recurrent glioblastoma?
Cancer Treat Rev. 2020 May 4;87:102029. doi: 10.1016/j.ctrv.2020.102029. PMID: 32408220. Review. ˍ




Huang AZ, Delaidelli A, Sorensen PH.
RNA modifications in brain tumorigenesis.
Acta Neuropathol Commun. 2020 May 6;8(1):64. doi: 10.1186/s40478-020-00941-6. PMID: 32375856. Review. ˍ




Soleman J, Kozyrev DA, Ben-Sira L, Constantini S, Roth J.
Management of incidental brain tumors in children: a systematic review.
Childs Nerv Syst. 2020 May 6;36(8):1607-1619. doi: 10.1007/s00381-020-04658-8. PMID: 32377829. Review. ˍ




Juškys R, Chomanskis Ž.
Glioblastoma Following Traumatic Brain Injury: Case Report and Literature Review.
Cureus. 2020 May 7;12(5):e8019. doi: 10.7759/cureus.8019. PMID: 32528758. Case report, Review. ˍ




Lu VM, Power EA, Zhang L, Daniels DJ.
Overcoming the blood brain barrier to target diffuse intrinsic pontine glioma: What's new?
World Neurosurg. 2020 May 7;139:618-619. doi: 10.1016/j.wneu.2020.05.008. PMID: 32389870. Review. ˍ




Muggia FM et al, PDQ Adult Treatment Editorial Board.
Adult Central Nervous System Tumors Treatment (PDQ®): Patient Version.
PDQ Cancer Inf Summ. 2020 May 7. NCBI Bookshelf ID: NBK66023. PMID: 26389458. Review. ˍ




Ritchey AK et al., PDQ Pediatric Treatment Editorial Board.
Childhood Brain and Spinal Cord Tumors Treatment Overview (PDQ®): Patient Version.
PDQ Cancer Inf Summ. 2020 May 7. NCBI Bookshelf ID: NBK65913. PMID: 26389351. Review. ˍ




Ritchey AK, et al., PDQ Pediatric Treatment Editorial Board.
Childhood Medulloblastoma and Other Central Nervous System Embryonal Tumors Treatment (PDQ®): Patient Version.
PDQ Cancer Inf Summ. 2020 May 7. NCBI Bookshelf ID: NBK65964. PMID: 26389401. Review. ˍ




Schiavolin S, Raggi A, Scaratti C, Toppo C, Silvaggi F, Sattin D, Broggi M, Ferroli P, Leonardi M.
Outcome prediction in brain tumor surgery: a literature review on the influence of nonmedical factors.
Neurosurg Rev. 2020 May 7;44(2):807-819. doi: 10.1007/s10143-020-01289-0. PMID: 32377881. Review. ˍ




Zeng Y, Zhu X, Wang Y, Liu B, Yang X, Wang Q, Du J, Ma Y, Lin L, Fu P, Xiao H, Guo QN.
Clinicopathological, Immunohistochemical and Molecular Genetic Study on Epithelioid Glioblastoma: A Series of Fifteen Cases with Literature Review.
Onco Targets Ther. 2020 May 8;13:3943-3952. doi: 10.2147/OTT.S249317. PMID: 32440157. Case report, Review. ˍ




Zhang C, Du J, Xu W, Huang H, Gao L.
The Value of Tumor Treating Fields in Glioblastoma.
J Korean Neurosurg Soc. 2020 May 8;63(6):681-688. doi: 10.3340/jkns.2019.0224. PMID: 32380584. Review. ˍ




Baliga S, Gandola L, Timmermann B, Gail H, Padovani L, Janssens GO, Yock TI.
Brain tumors: Medulloblastoma, ATRT, ependymoma.
Pediatr Blood Cancer. 2020 May 9, 2021;68 Suppl 2:e28395. doi: 10.1002/pbc.28395. PMID: 32386126. Review. ˍ




Suarez-Meade P, Marenco-Hillembrand L, Prevatt C, Murguia-Fuentes R, Mohamed A, Alsaeed T, Lehrer EJ, Brigham T, Ruiz-Garcia H, Sabsevitz D, Middlebrooks EH, Bechtle PS, Quinones-Hinojosa A, Chaichana KL.
Awake vs. asleep motor mapping for glioma resection: a systematic review and meta-analysis.
Acta Neurochir (Wien). 2020 May 9;162(7):1709-1720. doi: 10.1007/s00701-020-04357-y. PMID: 32388682. Review, Meta-analysis. ˍ




Cacciotti C, Fleming A, Ramaswamy V.
Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy.
J Pathol. 2020 May 11;251(3):249-261. doi: 10.1002/path.5457. PMID: 32391583. Review. ˍ




Kocher M, Ruge MI, Galldiks N, Lohmann P.
Applications of radiomics and machine learning for radiotherapy of malignant brain tumors.
Strahlenther Onkol. 2020 May 11;196(10):856-867. doi: 10.1007/s00066-020-01626-8. PMID: 32394100. Review. ˍ




Luo C, Xu S, Dai G, Xiao Z, Chen L, Liu Z.
Tumor treating fields for high-grade gliomas.
Biomed Pharmacother. 2020 May 11;127:110193. doi: 10.1016/j.biopha.2020.110193. PMID: 32407989. Review. ˍ




Rahman M, Sawyer WG, Lindhorst S, Deleyrolle LP, Harrison JK, Karachi A, Dastmalchi F, Flores-Toro J, Mitchell DA, Lim M, Gilbert MR, Reardon DA.
Adult Immuno-Oncology: Using Past Failures to Inform the Future.
Neuro Oncol. 2020 May 11;22(9):1249-1261. doi: 10.1093/neuonc/noaa116. PMID: 32391559. Meeting report. ˍ




Suvà ML, Tirosh I.
The Glioma Stem Cell Model in the Era of Single-Cell Genomics.
Cancer Cell. 2020 May 11;37(5):630-636. doi: 10.1016/j.ccell.2020.04.001. PMID: 32396858. Review. ˍ




de Blank P, Fouladi M, Huse JT.
Molecular markers and targeted therapy in pediatric low-grade glioma.
J Neurooncol. 2020 May 12;150(1):5-15. doi: 10.1007/s11060-020-03529-1. PMID: 32399739. Review. ˍ




Ferrer AI, Trinidad JR, Sandiford O, Etchegaray JP, Rameshwar P.
Epigenetic dynamics in cancer stem cell dormancy.
Cancer Metastasis Rev. 2020 May 12;39(3):721-738. doi: 10.1007/s10555-020-09882-x. PMID: 32394305. Review. ˍ




Lee A, Arasaratnam M, Chan DLH, Khasraw M, Howell VM, Wheeler H.
Anti-epidermal growth factor receptor therapy for glioblastoma in adults.
Cochrane Database Syst Rev. 2020 May 12;5(5):CD013238. doi: 10.1002/14651858.CD013238.pub2. PMID: 32395825. Meta-analysis. ˍ




Muir M, Gopakumar S, Traylor J, Lee S, Rao G.
Glioblastoma multiforme: novel therapeutic targets.
Expert Opin Ther Targets. 2020 May 12;24(7):605-614. doi: 10.1080/14728222.2020.1762568. PMID: 32394767. Review. ˍ




Garcia-Fabiani MB, Ventosa M, Comba A, Candolfi M, Nicola Candia AJ, Alghamri MS, Kadiyala P, Carney S, Faisal SM, Schwendeman A, Moon JJ, Scheetz L, Lahann J, Mauser A, Lowenstein PR, Castro MG.
Immunotherapy for gliomas: shedding light on progress in preclinical and clinical development.
Expert Opin Investig Drugs. 2020 May 13;29(7):659-684. doi: 10.1080/13543784.2020.1768528. PMID: 32400216. Review. ˍ




Verma V, Robinson CG, Rusthoven CG.
Hippocampal-Sparing Radiotherapy for Patients With Glioblastoma and Grade II-III Gliomas.
JAMA Oncol. 2020 May 14;6(7):981-983. doi: 10.1001/jamaoncol.2020.0164. PMID: 32407497. Editorial. ˍ




Deora H, Tripathi M, Tewari MK, Ahuja CK, Kumar N, Kaur A, Kamboj P.
Role of gamma knife radiosurgery in the management of intracranial gliomas.
Neurol India. 2020 May 15;68(2):290-298. doi: 10.4103/0028-3886.284356. PMID: 32415008. Review. ˍ